Lectura crítica
Adalimumab para el tratamiento de hidradenitis supurativa moderada a severa: estudio paralelo aleatorizado
Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial
J.R. Márquez Velásquez
Instituto de Coloproctología ICO, Clínica Las Américas, Medellín, Colombia
Leído
16205
Vecesse ha leído el artículo
1177
Total PDF
15028
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 68 | 6 | 74 |
| 2025 11 | 184 | 31 | 215 |
| 2025 10 | 235 | 8 | 243 |
| 2025 9 | 221 | 6 | 227 |
| 2025 8 | 171 | 17 | 188 |
| 2025 7 | 172 | 9 | 181 |
| 2025 6 | 199 | 4 | 203 |
| 2025 5 | 286 | 12 | 298 |
| 2025 4 | 283 | 4 | 287 |
| 2025 3 | 269 | 6 | 275 |
| 2025 2 | 293 | 7 | 300 |
| 2025 1 | 289 | 14 | 303 |
| 2024 12 | 243 | 7 | 250 |
| 2024 11 | 351 | 4 | 355 |
| 2024 10 | 302 | 14 | 316 |
| 2024 9 | 298 | 12 | 310 |
| 2024 8 | 283 | 12 | 295 |
| 2024 7 | 243 | 6 | 249 |
| 2024 6 | 291 | 9 | 300 |
| 2024 5 | 277 | 3 | 280 |
| 2024 4 | 309 | 10 | 319 |
| 2024 3 | 276 | 10 | 286 |
| 2024 2 | 232 | 8 | 240 |
| 2024 1 | 282 | 11 | 293 |
| 2023 12 | 166 | 12 | 178 |
| 2023 11 | 251 | 8 | 259 |
| 2023 10 | 298 | 21 | 319 |
| 2023 9 | 204 | 8 | 212 |
| 2023 8 | 200 | 19 | 219 |
| 2023 7 | 216 | 17 | 233 |
| 2023 6 | 242 | 9 | 251 |
| 2023 5 | 232 | 18 | 250 |
| 2023 4 | 184 | 3 | 187 |
| 2023 3 | 152 | 12 | 164 |
| 2023 2 | 136 | 7 | 143 |
| 2022 1 | 158 | 15 | 173 |
| 2022 12 | 127 | 8 | 135 |
| 2022 11 | 228 | 14 | 242 |
| 2022 10 | 174 | 20 | 194 |
| 2022 9 | 188 | 22 | 210 |
| 2022 8 | 172 | 29 | 201 |
| 2022 7 | 153 | 20 | 173 |
| 2022 6 | 123 | 10 | 133 |
| 2022 5 | 163 | 14 | 177 |
| 2022 4 | 162 | 14 | 176 |
| 2022 3 | 169 | 30 | 199 |
| 2022 2 | 144 | 12 | 156 |
| 2021 1 | 165 | 20 | 185 |
| 2021 12 | 101 | 21 | 122 |
| 2021 11 | 138 | 15 | 153 |
| 2021 10 | 156 | 28 | 184 |
| 2021 9 | 191 | 23 | 214 |
| 2021 8 | 116 | 10 | 126 |
| 2021 7 | 163 | 13 | 176 |
| 2021 6 | 134 | 13 | 147 |
| 2021 5 | 140 | 16 | 156 |
| 2021 4 | 500 | 20 | 520 |
| 2021 3 | 204 | 12 | 216 |
| 2021 2 | 177 | 13 | 190 |
| 2020 1 | 143 | 16 | 159 |
| 2020 12 | 123 | 28 | 151 |
| 2020 11 | 138 | 16 | 154 |
| 2020 10 | 95 | 11 | 106 |
| 2020 9 | 106 | 13 | 119 |
| 2020 8 | 103 | 16 | 119 |
| 2020 7 | 120 | 8 | 128 |
| 2020 6 | 99 | 4 | 103 |
| 2020 5 | 94 | 7 | 101 |
| 2020 4 | 71 | 4 | 75 |
| 2020 3 | 100 | 4 | 104 |
| 2020 2 | 107 | 8 | 115 |
| 2020 1 | 106 | 10 | 116 |
| 2019 12 | 79 | 10 | 89 |
| 2019 11 | 96 | 11 | 107 |
| 2019 10 | 125 | 15 | 140 |
| 2019 9 | 115 | 13 | 128 |
| 2019 8 | 62 | 18 | 80 |
| 2019 7 | 115 | 19 | 134 |
| 2019 6 | 86 | 35 | 121 |
| 2019 5 | 138 | 54 | 192 |
| 2019 4 | 77 | 12 | 89 |
| 2019 3 | 26 | 6 | 32 |
| 2019 2 | 24 | 13 | 37 |
| 2019 1 | 21 | 13 | 34 |
| 2018 12 | 10 | 12 | 22 |
| 2018 11 | 27 | 4 | 31 |
| 2018 10 | 32 | 8 | 40 |
| 2018 9 | 13 | 4 | 17 |
| 2018 8 | 4 | 3 | 7 |
| 2018 7 | 8 | 0 | 8 |
| 2018 6 | 9 | 1 | 10 |
| 2018 5 | 15 | 0 | 15 |
| 2018 4 | 21 | 0 | 21 |
| 2018 3 | 6 | 0 | 6 |
| 2018 2 | 6 | 0 | 6 |
| 2018 1 | 7 | 0 | 7 |
| 2017 3 | 2 | 0 | 2 |
| 2017 2 | 1 | 0 | 1 |
| 2016 10 | 5 | 0 | 5 |
| 2016 7 | 1 | 1 | 2 |
| 2016 5 | 1 | 0 | 1 |
| 2016 4 | 4 | 2 | 6 |
| 2016 3 | 3 | 2 | 5 |
Mostrar todo
